CHINWAGYThe world's live brand collaboration wire
Join freeCreatorsIndustryContact
For you +
ReadersCreatorsBrands & IndustryContact Chinwagy

THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Gilead and Galapagos collaborate on autoimmune-disease T-cell engager program

Gilead Sciences×Galapagos NV

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Gilead and Galapagos announced a binding agreement to collaborate on advancing a potential first-in-class T-cell engager program for autoimmune diseases.

Current status
Reported collaboration
Known availability
The published source describes the collaboration; timing details remain under review.
Place
Mechelen, Belgium
Source checked
September 18, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.